Ahmed Z Alanazi Selected Research

Drug Therapy (Chemotherapy)

1/2020	LCZ696 mitigates diabetic-induced nephropathy through inhibiting oxidative stress, NF-κB mediated inflammation and glomerulosclerosis in rats.
1/2019	Apremilast ameliorates carfilzomib-induced pulmonary inflammation and vascular injuries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmed Z Alanazi Research Topics

Disease

8	Inflammation (Inflammations) 12/2023 - 01/2020
4	Neoplasms (Cancer) 01/2024 - 01/2019
2	Autistic Disorder (Autism) 03/2024 - 10/2019
2	Neuroinflammatory Diseases 03/2024 - 10/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 01/2019
2	Vascular System Injuries 10/2023 - 01/2019
2	Leukemia 10/2023 - 06/2023
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 08/2022
2	Hyperglycemia 08/2023 - 01/2020
2	Liver Diseases (Liver Disease) 06/2023 - 01/2020
2	Fibrosis (Cirrhosis) 01/2023 - 01/2020
2	Cardiotoxicity 08/2022 - 09/2021
2	Wounds and Injuries (Trauma) 01/2020 - 01/2020
1	Infections 02/2024
1	Hepatocellular Carcinoma (Hepatoma) 10/2023
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2023
1	Breast Neoplasms (Breast Cancer) 06/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Cardiomegaly (Heart Hypertrophy) 08/2022
1	Otitis 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Multiple Myeloma 01/2019
1	Acute Lung Injury 01/2019
1	Pneumonia (Pneumonitis) 01/2019

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 03/2024 - 10/2019
5	AntioxidantsIBA 12/2023 - 01/2020
3	Dasatinib (BMS 354825)FDA Link 10/2023 - 01/2023
3	Tyrosine Kinase InhibitorsIBA 10/2023 - 08/2022
2	LipopolysaccharidesIBA 03/2024 - 06/2023
2	Imiquimod (Aldara)FDA LinkGeneric 12/2023 - 01/2022
2	Interleukin-17 (Interleukin 17)IBA 12/2023 - 01/2022
2	Streptozocin (Streptozotocin)FDA Link 08/2023 - 01/2020
2	EnzymesIBA 08/2023 - 01/2020
2	p38 Mitogen-Activated Protein KinasesIBA 08/2022 - 01/2022
2	Valsartan (Vals)FDA Link 09/2021 - 01/2020
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020 - 01/2020
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	Vancomycin FDA LinkGeneric 02/2024
1	CarbonIBA 01/2024
1	Methotrexate (Mexate)FDA LinkGeneric 01/2024
1	NitrogenIBA 01/2024
1	Cisplatin (Platino)FDA LinkGeneric 01/2024
1	Etoposide (VP 16)FDA LinkGeneric 01/2024
1	Diethylhexyl Phthalate (DEHP)IBA 12/2023
1	Oxidants (Oxidizing Agents)IBA 12/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2023
1	phthalic acid (phthalate)IBA 12/2023
1	nilotinib FDA Link 10/2023
1	Sorafenib (BAY 43-9006)FDA Link 10/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2023
1	Messenger RNA (mRNA)IBA 10/2023
1	cabozantinibIBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023
1	LipidsIBA 08/2023
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2023
1	naringeninIBA 06/2023
1	diazobenzenesulfonic acid (DASA)IBA 06/2023
1	CalciumIBA 06/2023
1	ThapsigarginIBA 06/2023
1	Toll-Like Receptor 4IBA 06/2023
1	Dinoprostone (PGE2)FDA Link 06/2023
1	Reticulin (Reticular Fiber)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 08/2022
1	Angiotensin IIIBA 08/2022
1	Gefitinib (Iressa)FDA Link 08/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2022
1	Mitogen-Activated Protein KinasesIBA 08/2022
1	Type 1 Angiotensin ReceptorIBA 08/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	1-methyl-1H-indole-2-carboxylic acid (4- (1- (4- (4- acetylpiperazin- 1- yl)cyclohexyl)- 4- amino- 1H- pyrazolo(3,4- d)pyrimidin- 3- yl)- 2- methoxyphenyl)amideIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021
1	Transaminases (Aminotransferases)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Ketamine FDA LinkGeneric 01/2020
1	perampanelIBA 01/2020
1	Chemokine ReceptorsIBA 10/2019
1	Therapeutic UsesIBA 10/2019
1	NSC 74859IBA 10/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Proteasome InhibitorsIBA 01/2019
1	carfilzomibIBA 01/2019
1	apremilastIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019

Therapy/Procedure

5	Therapeutics 01/2024 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2019